Syndax Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Syndax Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $39.25. The average 1-year stock price forecast is 102.22% higher than the current stock price, while the lowest is $29 (+49.41%) and the highest is $57 (+193.66%).

Price Target: $39.25 (+102.22%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$29	$39.25	$37	$57
Change	+49.41%	+102.22%	+90.62%	+193.66%

Analyst Ratings

The average analyst rating for Syndax Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	8	8	8	8	8	7
Buy	3	3	3	4	4	4
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	13	13	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Dai UBS	UBS	Strong Buy Maintains $38 → $37	Strong Buy	Maintains	$38 → $37	+90.62%	May 13, 2026
Etzer Darout Barclays	Barclays	Buy Maintains $35 → $37	Buy	Maintains	$35 → $37	+90.62%	May 1, 2026
Corinne Johnson Goldman Sachs	Goldman Sachs	Strong Buy Maintains $28 → $34	Strong Buy	Maintains	$28 → $34	+75.17%	Apr 1, 2026
Salim Syed Mizuho	Mizuho	Buy Maintains $45 → $43	Buy	Maintains	$45 → $43	+121.54%	Mar 31, 2026
Faisal Khurshid Jefferies	Jefferies	Strong Buy Initiates $48 → $40	Strong Buy	Initiates	$48 → $40	+106.08%	Mar 30, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

353.55M

from 172.35M

105.13%

from 172.35M

Revenue Next Year

503.15M

from 353.55M

42.31%

from 353.55M

EPS This Year

-1.72

from -3.29

EPS Next Year

-0.52

from -1.72

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	139.71M	-	-	23.68M	172.35M	353.55M	503.15M
Revenue Growth	9,109.56%	-	-	-	627.84%	105.13%	42.31%
EPS	0.46	-2.46	-2.98	-3.72	-3.29	-1.72	-0.52
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	416.2M	647.4M
Avg	353.6M	503.2M
Low	292.5M	397.5M

Revenue Growth

Revenue Growth	2026	2027
High	141.5%	83.1%
Avg	105.1%	42.3%
Low	69.7%	12.4%

EPS Forecast

EPS	2026	2027
High	-0.71	1.10
Avg	-1.72	-0.52
Low	-2.53	-1.55

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.